PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HROW vs. CAVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


HROWCAVA
YTD Return413.21%217.17%
1Y Return306.79%313.09%
Sharpe Ratio2.965.45
Sortino Ratio3.504.92
Omega Ratio1.561.68
Calmar Ratio2.866.70
Martin Ratio13.7747.50
Ulcer Index19.55%6.43%
Daily Std Dev90.81%56.09%
Max Drawdown-99.46%-47.50%
Current Drawdown-58.35%0.00%

Fundamentals


HROWCAVA
Market Cap$2.00B$15.34B
EPS-$0.95$0.17
Total Revenue (TTM)$119.88M$669.67M
Gross Profit (TTM)$85.49M$124.20M
EBITDA (TTM)-$630.00K$80.80M

Correlation

-0.50.00.51.00.2

The correlation between HROW and CAVA is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

HROW vs. CAVA - Performance Comparison

In the year-to-date period, HROW achieves a 413.21% return, which is significantly higher than CAVA's 217.17% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%MayJuneJulyAugustSeptemberOctober
442.30%
128.69%
HROW
CAVA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HROW vs. CAVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and CAVA Group Inc. (CAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HROW
Sharpe ratio
The chart of Sharpe ratio for HROW, currently valued at 3.40, compared to the broader market-4.00-2.000.002.004.003.40
Sortino ratio
The chart of Sortino ratio for HROW, currently valued at 3.76, compared to the broader market-4.00-2.000.002.004.006.003.76
Omega ratio
The chart of Omega ratio for HROW, currently valued at 1.61, compared to the broader market0.501.001.502.001.61
Calmar ratio
The chart of Calmar ratio for HROW, currently valued at 4.85, compared to the broader market0.002.004.006.004.85
Martin ratio
The chart of Martin ratio for HROW, currently valued at 15.69, compared to the broader market-10.000.0010.0020.0030.0015.69
CAVA
Sharpe ratio
The chart of Sharpe ratio for CAVA, currently valued at 5.45, compared to the broader market-4.00-2.000.002.004.005.45
Sortino ratio
The chart of Sortino ratio for CAVA, currently valued at 4.92, compared to the broader market-4.00-2.000.002.004.006.004.92
Omega ratio
The chart of Omega ratio for CAVA, currently valued at 1.68, compared to the broader market0.501.001.502.001.68
Calmar ratio
The chart of Calmar ratio for CAVA, currently valued at 6.70, compared to the broader market0.002.004.006.006.70
Martin ratio
The chart of Martin ratio for CAVA, currently valued at 47.50, compared to the broader market-10.000.0010.0020.0030.0047.50

HROW vs. CAVA - Sharpe Ratio Comparison

The current HROW Sharpe Ratio is 2.96, which is lower than the CAVA Sharpe Ratio of 5.45. The chart below compares the historical Sharpe Ratios of HROW and CAVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00Jun 23Jun 30Jul 07Jul 14Jul 21Jul 28Aug 04Aug 11Aug 18Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13Oct 20
3.40
5.45
HROW
CAVA

Dividends

HROW vs. CAVA - Dividend Comparison

Neither HROW nor CAVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HROW vs. CAVA - Drawdown Comparison

The maximum HROW drawdown since its inception was -99.46%, which is greater than CAVA's maximum drawdown of -47.50%. Use the drawdown chart below to compare losses from any high point for HROW and CAVA. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%MayJuneJulyAugustSeptemberOctober00
HROW
CAVA

Volatility

HROW vs. CAVA - Volatility Comparison

Harrow Health, Inc. (HROW) has a higher volatility of 11.76% compared to CAVA Group Inc. (CAVA) at 6.85%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than CAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%MayJuneJulyAugustSeptemberOctober
11.76%
6.85%
HROW
CAVA

Financials

HROW vs. CAVA - Financials Comparison

This section allows you to compare key financial metrics between Harrow Health, Inc. and CAVA Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items